Cost-Effectiveness of Genetic Testing in Family Members of Patients With Long-QT Syndrome
- 1 January 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Cardiovascular Quality and Outcomes
- Vol. 4 (1), 76-84
- https://doi.org/10.1161/circoutcomes.110.957365
Abstract
Background— Family members of patients with established long-QT syndrome (LQTS) often lack definitive clinical findings, yet may have inherited an LQTS mutation and be at risk of sudden death. Genetic testing can identify mutations in 75% of patients with LQTS, but genetic testing of family members remains controversial. Methods and Results— We used a Markov model to assess the cost-effectiveness of 3 strategies for treating an asymptomatic 10-year-old, first-degree relative of a patient with clinically evident LQTS. In the genetic testing strategy, relatives undergo genetic testing only for the mutation identified in the index patient, and relatives who test positive for the mutation are treated with β-blockers. This strategy was compared with (1) empirical treatment of relatives with β-blockers and (2) watchful waiting, with treatment only after development of symptoms. The genetic testing strategy resulted in better survival and quality-adjusted life years at higher cost, with a cost-effectiveness ratio of $67 400 per quality-adjusted life year gained compared with watchful waiting. The cost-effectiveness of the genetic testing strategy improved to less than $50 000 per quality-adjusted life year gained when applied selectively either to (1) relatives with higher clinical suspicion of LQTS (pretest probability 65% to 81%), or to (2) families with a higher than average risk of sudden death, or to (3) larger families (2 or more first-degree relatives tested). Conclusions— Genetic testing of young first-degree relatives of patients with definite LQTS is moderately expensive, but can reach acceptable thresholds of cost-effectiveness when applied to selected patients.Keywords
This publication has 39 references indexed in Scilit:
- Prevalence of the Congenital Long-QT SyndromeCirculation, 2009
- Genetic Testing for Long-QT SyndromeCirculation, 2009
- Mutations in Conserved Amino Acids in the KCNQ1 Channel and Risk of Cardiac Events in Type‐1 Long‐QT SyndromeJournal of Cardiovascular Electrophysiology, 2009
- Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 GeneCirculation, 2007
- Influence of the Genotype on the Clinical Course of the Long-QT SyndromeThe New England Journal of Medicine, 1998
- The Molecular Ggenetics of the Long QT Syndrome: Genes Causing Fainting and Sudden DeathAnnual Review of Medicine, 1998
- Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmiasNature Genetics, 1996
- Markov Models in Medical Decision MakingMedical Decision Making, 1993
- Linkage of a Cardiac Arrhythmia, the Long QT Syndrome, and the Harvey ras -1 GeneScience, 1991
- The Effects of Antihypertensive Therapy on the Quality of LifeThe New England Journal of Medicine, 1986